Robert G. Uzzo

Also affiliated with Temple University Health System

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 20 papers. Top paper: “Perioperative nivolumab versus observation in patients with renal cell carcinoma undergoing nephrectomy (PROSPER ECOG-ACRIN EA8143): an open-label, randomised, phase 3 study”.

Perioperative nivolumab versus observation in patients with renal cell carcinoma undergoing nephrectomy (PROSPER ECOG-ACRIN EA8143): an open-label, randomised, phase 3 study

The Lancet Oncology(2024)10.1016/s1470-2045(24)00211-0

N/A

1.9DataRank · unranked

86 citations

Se-Eun Kim, Viraj A. Master, David H. McDermott, Lauren C. Harshman, Suzanne Cole +40 more

Adjuvant everolimus after surgery for renal cell carcinoma (EVEREST): a double-blind, placebo-controlled, randomised, phase 3 trial

The Lancet(2023)10.1016/s0140-6736(23)00913-3

N/A

1.4DataRank · unranked

49 citations

Catherine M. Tangen, Elisabeth I. Heath, Mark N. Stein, Maxwell V. Meng, Ajjai Alva +14 more

Multi-ancestry genome-wide association study of kidney cancer identifies 63 susceptibility regions

Nature Genetics(2024)10.1038/s41588-024-01725-7

N/A

0.987DataRank · unranked

51 citations

Diptavo Dutta, Mitchell J. Machiela, Bryan R. Gorman, Timothy Winter, Dayne Okuhara +95 more

Summary From the First Kidney Cancer Research Summit, September 12–13, 2019: A Focus on Translational Research

JNCI Journal of the National Cancer Institute(2020)10.1093/jnci/djaa064

N/A

0.557DataRank · unranked

40 citations

Michael B. Atkins, Ziad Bakouny, Maria I. Carlo, Charles G. Drake, Eric Jonasch +15 more

Urine Biopsy as Dynamic Biomarker to Enhance Clinical Staging of Bladder Cancer in Radical Cystectomy Candidates

JCO Precision Oncology(2024)10.1200/po.23.00362

N/A

0.262DataRank · unranked

3 citations

Henkel Valentine, David Liu, Michael J. Slifker, Costas D. Lallas, Edouard J. Trabulsi +24 more

Human Gut Mycobiome and Fungal Community Interaction: The Unknown Musketeer in the Chemotherapy Response Status in Bladder Cancer

European Urology Open Science(2022)10.1016/j.euros.2022.06.005

N/A

0DataRank · unranked

26 citations

Megan Prunty, Ilaha Isali, Adam Calaway, Rashida Ginwala, Mohit Sindhani +7 more

Long-Term Results of a Phase 3 Randomized Prospective Trial of Erectile Tissue-Sparing Intensity-Modulated Radiation Therapy for Men With Clinically Localized Prostate Cancer

International Journal of Radiation Oncology*Biology*Physics(2022)10.1016/j.ijrobp.2022.12.008

N/A

0DataRank · unranked

16 citations

Karen Ruth, Mark K. Buyyounouski, R Price, Robert G. Uzzo, Mark L. Sobczak +9 more

Acetyl-CoA Counteracts the Inhibitory Effect of Antiandrogens on Androgen Receptor Signaling in Prostate Cancer Cells

Cancers(2022)10.3390/cancers14235900

N/A

0DataRank · unranked

4 citations

Rushaniya Fazliyeva, Antonio Tufano, Robert G. Uzzo, Kathy Q. Cai, Ilya G. Serebriiskii +4 more

EVEREST: Everolimus for renal cancer ensuing surgical therapy—A phase III study (SWOG S0931, NCT01120249).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.17_suppl.lba4500

N/A

0DataRank · unranked

39 citations

Catherine M. Tangen, Elisabeth I. Heath, Mark N. Stein, Maxwell V. Meng, Ajjai Alva +15 more

Localised non‐metastatic sarcomatoid renal cell carcinoma: a 31‐year externally verified study

British Journal of Urology(2023)10.1111/bju.16125

N/A

0DataRank · unranked

7 citations

Andrew W. Silagy, Andrea Knežević, Stanley Weng, Alan Wang, Roy Mano +13 more

Role of Gut Microbiome in Neoadjuvant Chemotherapy Response in Urothelial Carcinoma: A Multi-Institutional Prospective Cohort Evaluation

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.01.21.525021

N/A

0DataRank · unranked

7 citations

Rashida Ginwala, Mohit Sindhani, Megan Prunty, Daniel M. Geynisman, Pooja Ghatalia +15 more

Transcriptome- and proteome-wide association studies identify genes associated with renal cell carcinoma

The American Journal of Human Genetics(2024)10.1016/j.ajhg.2024.07.012

N/A

0DataRank · unranked

10 citations

Xinyu Guo, Timothy Winter, Om Jahagirdar, Mark P. Purdue, Mitchell J. Machiela +93 more

Targeting NPC1 in Renal Cell Carcinoma

Cancers(2024)10.3390/cancers16030517

N/A

0DataRank · unranked

5 citations

Peter Makhov, Robert G. Uzzo, Vladimir Kolenko, Rushaniya Fazliyeva

Normalized total psoas area predicts early postoperative mobility and perioperative adverse events after adult spinal deformity surgery

The Spine Journal(2024)10.1016/j.spinee.2024.11.014

N/A

0DataRank · unranked

5 citations

Han Jo Kim, Myles Allen, Chukwuebuka C. Achebe, Michael Mazzucco, Robert G. Uzzo +11 more

Adjuvant Everolimus in Patients with Completely Resected, Very High-risk Renal Cell Carcinoma of Clear Cell Histology: Results from the Phase 3 Placebo-controlled SWOG S0931 (EVEREST) Trial

European Urology(2024)10.1016/j.eururo.2024.05.012

N/A

0DataRank · unranked

8 citations

Catherine M. Tangen, Elisabeth I. Heath, Shuchi Gulati, Mark N. Stein, Maxwell V. Meng +16 more

Using Mendelian randomization to investigate etiologic heterogeneity across renal cell carcinoma subtypes

International Journal of Epidemiology(2025)10.1093/ije/dyaf177

N/A

0DataRank · unranked

1 citations

Om Jahagirdar, Mark P. Purdue, Diptavo Dutta, Mitchell J. Machiela, Bryan R. Gorman +94 more

CRISPR/Cas9 genome-wide loss-of-function screening identifies druggable cellular factors involved in sunitinib resistance in renal cell carcinoma

British Journal of Cancer(2020)10.1038/s41416-020-01087-x

N/A

0DataRank · unranked

28 citations

Ji A. Sohn, Ilya G. Serebriiskii, Rushaniya Fazliyeva, Vladimir Khazak, Yanis Boumber +3 more

Trends in Radical Prostatectomy: Centralization, Robotics, and Access to Urologic Cancer Care

UNC Libraries(2020)10.17615/j1yv-5y65

N/A

0DataRank · unranked

0 citations

Robert G. Uzzo, Yu Ning Wong, Karyn B. Stitzenberg, Matthew E. Nielsen, Brian L. Egleston

Plasma KIM-1 Is Associated with Recurrence Risk after Nephrectomy for Localized Renal Cell Carcinoma: A Trial of the ECOG-ACRIN Research Group (E2805)

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-21-0025

N/A

0DataRank · unranked

46 citations

Mäneka Puligandla, Brian Halbert, Naomi B. Haas, Keith T. Flaherty, Robert G. Uzzo +5 more

BAP1 maintains HIF-dependent interferon beta induction to suppress tumor growth in clear cell renal cell carcinoma

Cancer Letters(2022)10.1016/j.canlet.2022.215885

N/A

0DataRank · unranked

37 citations

Rayan El Hajjar, He Shen, Eleonora Sementino, Zhijiu Zhong, Wei Jiang +6 more